| Quantity: | |
|---|---|
FY-P023
The OEM V1 1mg Semaglutide Pen is an advanced drug delivery solution designed specifically for GLP-1 therapies, including semaglutide, liraglutide, and similar peptide-based treatments. Engineered for high precision and patient-friendly usability, this model supports dosing measured in milligrams, catering to therapies where exact concentration-based dosing is critical.
1mg Precision Dosing
Specifically calibrated for 1mg dose delivery, ensuring clinical accuracy for semaglutide treatment.
Reduces variability in patient administration, promoting consistent therapeutic outcomes.
Customizable Scale & Branding
Fully customizable scale markings (mg-based or hybrid units), enhancing clarity for patients and healthcare providers.
Brand identity can be seamlessly integrated through logos, colors, surface finishes, and packaging designs, supporting pharmaceutical partners in market positioning.
Drug Compatibility
Optimized for GLP-1 drugs such as semaglutide, liraglutide, and dulaglutide.
Compatible with 3ml ISO11608-3 compliant cartridges for global use.
Suitable for biologics and peptide formulations requiring precision dosing.
Ergonomic V1 Structure
Classic pen clip design enhances portability and professional appearance.
Smooth actuation system designed for ease of use and patient comfort, even for long-term self-injection therapies.
OEM/ODM Flexibility
Options for dose scale customization, external design, materials, and packaging.
Sunrise provides end-to-end services, including matched needles, cartridges, and pen cases, forming a complete delivery ecosystem.
Global Compliance & Quality Assurance
Manufactured in alignment with ISO11608-1/2/3 standards.
Passed comprehensive testing including environmental stress, drop, vibration, and accelerated aging studies.
Unlike traditional unit-based pens, the 1mg model is designed for concentration-specific dosing, offering greater flexibility for clinical applications and patient needs. With Sunrise’s decade-long expertise, OEM customization capabilities, and strict compliance, pharmaceutical partners can launch therapies with confidence, differentiation, and global readiness.
The OEM V1 1mg Semaglutide Pen is an advanced drug delivery solution designed specifically for GLP-1 therapies, including semaglutide, liraglutide, and similar peptide-based treatments. Engineered for high precision and patient-friendly usability, this model supports dosing measured in milligrams, catering to therapies where exact concentration-based dosing is critical.
1mg Precision Dosing
Specifically calibrated for 1mg dose delivery, ensuring clinical accuracy for semaglutide treatment.
Reduces variability in patient administration, promoting consistent therapeutic outcomes.
Customizable Scale & Branding
Fully customizable scale markings (mg-based or hybrid units), enhancing clarity for patients and healthcare providers.
Brand identity can be seamlessly integrated through logos, colors, surface finishes, and packaging designs, supporting pharmaceutical partners in market positioning.
Drug Compatibility
Optimized for GLP-1 drugs such as semaglutide, liraglutide, and dulaglutide.
Compatible with 3ml ISO11608-3 compliant cartridges for global use.
Suitable for biologics and peptide formulations requiring precision dosing.
Ergonomic V1 Structure
Classic pen clip design enhances portability and professional appearance.
Smooth actuation system designed for ease of use and patient comfort, even for long-term self-injection therapies.
OEM/ODM Flexibility
Options for dose scale customization, external design, materials, and packaging.
Sunrise provides end-to-end services, including matched needles, cartridges, and pen cases, forming a complete delivery ecosystem.
Global Compliance & Quality Assurance
Manufactured in alignment with ISO11608-1/2/3 standards.
Passed comprehensive testing including environmental stress, drop, vibration, and accelerated aging studies.
Unlike traditional unit-based pens, the 1mg model is designed for concentration-specific dosing, offering greater flexibility for clinical applications and patient needs. With Sunrise’s decade-long expertise, OEM customization capabilities, and strict compliance, pharmaceutical partners can launch therapies with confidence, differentiation, and global readiness.
